Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)
- Authors
- Lee, J. W.; Lee, Y-g.; Lee, G-w.; Jung, H. A.; Kim, K-p.; Kim, T-y.; Ryu, H.; Ryu, M. H.; Ahn, M. S.; Yun, H.; Ahn, S.; Shim, H. S.; Kim, J.; Sim, J.; Kim, S. Y.; Kim, J. H.; Lee, S.
- Issue Date
- Dec-2024
- Publisher
- Oxford University Press
- Citation
- Annals of Oncology, v.35, pp S1580 - S1580
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 35
- Start Page
- S1580
- End Page
- S1580
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.